Exercise News and Research

Latest Exercise News and Research

JANUMET results in greater blood sugar reductions in patients with type 2 diabetes compared to pioglitazone

New data were presented at the American Diabetes Association 70th Annual Scientific Sessions from a study comparing JANUMET (sitagliptin/metformin) to pioglitazone. In this study, JANUMET resulted in significantly greater blood sugar reductions in patients with type 2 diabetes compared with pioglitazone.

28 Jun 2010

EpiCept signs definitive agreements for purchase of 6.1M shares of common stock

EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.

28 Jun 2010

Phase III clinical trials: Linagliptin achieves significant, sustained reductions in blood sugar

Data from four pivotal Phase III clinical trials demonstrate that linagliptin achieved statistically significant and sustained reductions in blood sugar as measured by hemoglobin A1c, fasting plasma glucose and postprandial glucose. Boehringer Ingelheim Pharmaceuticals, Inc. is investigating the dipeptidyl peptidase 4 inhibitor as an oral once-daily tablet, as monotherapy and combination therapy, to treat type 2 diabetes.

28 Jun 2010

Researchers discover genetic links to kidney failure, diabetic kidney disease

Researchers at the Translational Genomics Research Institute will make two presentations at this week's 70th Scientific Sessions of the American Diabetes Association, June 25-29, in Orlando, Florida.

28 Jun 2010

Data shows Victoza produces greater reductions in A1c, body weight and FPG than Januvia

Late-breaking Novo Nordisk extension data presented today at the 70th Annual Scientific Sessions of the American Diabetes Association showed that once-daily Victoza in combination with metformin produced sustained and significantly greater reductions in A1c, body weight and fasting plasma glucose than Januvia plus metformin at 52 weeks.

28 Jun 2010

Neuralstem signs definitive agreements to sell $10M of units in registered-direct offering

Neuralstem, Inc. announced today that it has entered into definitive agreements to sell $10 million of units at $2.80 per unit in a registered-direct offering to institutional investors. The units consist of: (i) one share of common stock, and (ii) 3/4 common stock purchase warrant. The warrants have an exercise price of $3.25 and a term of three years.

25 Jun 2010

CDP treatment can reduce pain and swelling in CVI patients

For patients with painful swelling of the legs caused by chronic venous insufficiency (CVI), a combination treatment approach called "complete decongestive physiotherapy" improves symptoms, walking ability, and quality of life, reports a study in Topics in Geriatric Rehabilitation.

25 Jun 2010

Cardio-respiratory aerobic exercise reduces joint pain in RA patients

Researchers from the University of Grenoble Medical School in France determined that cardio-respiratory aerobic exercise is safe for patients with stable rheumatoid arthritis (RA).

25 Jun 2010

Palatin announces completion of patient dosing, database lock in bremelanotide study for ED

Palatin Technologies, Inc. today announced the completion of patient dosing and database lock in a double-blind, placebo-controlled, multiple dose, crossover study of bremelanotide, its subcutaneously administered melanocortin agonist for treatment of erectile dysfunction (ED). Palatin expects to report top-line data in the next calendar quarter.

24 Jun 2010

Blood flow disturbances in artery determine appearance of atherosclerosis: Study

A new animal model of atherosclerosis has allowed researchers to identify a host of genes turned on or off during the initial stages of the process, before a plaque appears in the affected blood vessel.

24 Jun 2010

Association for Nutrition to be launched at The Royal Society in London

The launch of Association for Nutrition will take place today at The Royal Society in London. AfN is the professional body for the regulation and registration of nutritionists, embracing those involved in public health, care, food, exercise, policy and those who work with animals. One of the Association's responsibilities is running the UK Voluntary Register of Nutritionists.

24 Jun 2010

Merck's DULERA Inhalation Aerosol for asthma receives FDA approval

Merck today announced that the U.S. Food and Drug Administration (FDA) has approved DULERA® (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol, a new fixed-dose combination asthma treatment for patients 12 years of age and older. DULERA is not indicated for the relief of acute bronchospasm. DULERA combines an inhaled corticosteroid (mometasone furoate) with a long-acting beta2-agonist (formoterol fumarate).

24 Jun 2010

UCSD School of Medicine receives $5.3M grant to study effect of weight loss in breast cancer survivors

The University of California, San Diego School of Medicine has received a $5.3 million grant from the National Cancer Institute to conduct and lead a first-of-its-kind, four-year clinical trial to show the effects of weight loss and increased physical activity on quality of life and on co-existing medical conditions in overweight breast cancer survivors.

24 Jun 2010

United Seating & Mobility launches new redesigned website, expands e-commerce store

United Seating & Mobility, the nation's largest privately-owned mobility and rehab equipment supplier, has launched a newly redesigned website at www.UnitedSeating.com. The new site features in-depth information for clients and families, providing easy to follow information on today's mobility options, as well as background company information and coverage explanations for healthcare professionals and health care plan employees.

24 Jun 2010

Ingredients for an "anti-aging potion"

Aging without getting old? It's largely possible, according to the June issue of Mayo Clinic Health Letter.

24 Jun 2010

Spherix to explore triglycerides for D-tagatose therapy

Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.

24 Jun 2010

Positive results from Phase II PK study for Topical Interferon Alpha-2b announced

Helix BioPharma Corp. today announced positive Phase II pharmacokinetic findings for Topical Interferon Alpha-2b in patients with low-grade cervical lesions.

24 Jun 2010

BioSante closes $15 million registered direct offering

BioSante Pharmaceuticals, Inc. today announced closing of a previously announced sale of an aggregate of $15 million of securities in a registered direct offering. The investors are Deerfield Management Company and other institutional investors. BioSante received net proceeds of approximately $14.2 million after deducting placement agent fees and other offering expenses.

24 Jun 2010

Tikcro Technologies reports net income of $1.9 million for first-quarter 2010

Tikcro Technologies Ltd. today reported results for the first quarter ended March 31, 2010.

24 Jun 2010

SOKO Fitness & Spa Group opens Daoli Fitness and Legend Spa Central Club in Harbin, China

SOKO Fitness & Spa Group, Inc., an operator of fitness centers, beauty salons and spas in Northeast China as well as suburban Beijing, today announced the opening of its two newest facilities, Daoli Fitness and Legend Spa Central Club. Both centers, which, as previously announced, have been engaged in pre-opening activities for several months, are located in the Long Dian Building in downtown Harbin, China, a centrally located building for SOKO's target upper-middle class clients.

23 Jun 2010

Exercise News and Research

Latest Exercise News and Research

JANUMET results in greater blood sugar reductions in patients with type 2 diabetes compared to pioglitazone

EpiCept signs definitive agreements for purchase of 6.1M shares of common stock

Phase III clinical trials: Linagliptin achieves significant, sustained reductions in blood sugar

Researchers discover genetic links to kidney failure, diabetic kidney disease

Data shows Victoza produces greater reductions in A1c, body weight and FPG than Januvia

Neuralstem signs definitive agreements to sell $10M of units in registered-direct offering

CDP treatment can reduce pain and swelling in CVI patients

Cardio-respiratory aerobic exercise reduces joint pain in RA patients

Palatin announces completion of patient dosing, database lock in bremelanotide study for ED

Blood flow disturbances in artery determine appearance of atherosclerosis: Study

Association for Nutrition to be launched at The Royal Society in London

Merck's DULERA Inhalation Aerosol for asthma receives FDA approval

UCSD School of Medicine receives $5.3M grant to study effect of weight loss in breast cancer survivors

United Seating & Mobility launches new redesigned website, expands e-commerce store

Ingredients for an "anti-aging potion"

Spherix to explore triglycerides for D-tagatose therapy

Positive results from Phase II PK study for Topical Interferon Alpha-2b announced

BioSante closes $15 million registered direct offering

Tikcro Technologies reports net income of $1.9 million for first-quarter 2010

SOKO Fitness & Spa Group opens Daoli Fitness and Legend Spa Central Club in Harbin, China

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Exercise News and Research

Latest Exercise News and Research

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Newsletters you may be interested in